0QLR.L vs. 0P6S.L

Last updated Jun 6, 2026

0QLR.L (Novartis AG) and 0P6S.L (Bayer AG NA) are both stocks. Both operate in the Drug Manufacturers - General industry within the Healthcare sector.

Performance

0QLR.L vs. 0P6S.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Novartis AG (0QLR.L) and Bayer AG NA (0P6S.L). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

0QLR.L is traded in GBP, while 0P6S.L is traded in EUR. To make them comparable, the 0P6S.L values have been converted to GBP using the latest available exchange rates.

Returns By Period

0QLR.L

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

0P6S.L

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

0QLR.L vs. 0P6S.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (0QLR.L) and Bayer AG NA (0P6S.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Drawdowns

Volatility

Dividends

0QLR.L vs. 0P6S.L - Dividend Comparison

Neither 0QLR.L nor 0P6S.L has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials